None listed
Conditions
Interventions
Intervention1: Trans-Resveratrol tablets: Dose: 1 pill at bed time for 4 weeks, Route of Administration: Orally Frequency: Once a day Duration of study: 4 weeks
Control Intervention1: Not Applicable:
Sponsors
Miror Therapeutics Pvt Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1. Voluntary man or women between 18 and 50 years. 2. Having either of the general health issues- any digestive/ cognitive/ Low Energy levels 3. For whom the investigator considers that the compliance will be correct. 4. Cooperating, informed of the need and duration of the examinations and ready to comply with protocol procedures. 5. Having signed a Consent Form. 6. Should be able to read and write (in English, Hindi or local language). 7. Having valid proof of identity and age.
Exclusion criteria
Exclusion criteria: 1. Pregnant or nursing mothers 2.Chronic illness which may influence the outcome of the study 3.Any medical past history 4.Dermatological infection or pathology on the level of studied area 5.Hypersensitivity, allergy antecedent (to any cosmetic product, raw material or hair dye) 6.Any clinically significant systemic or cutaneous disease, which may interfere with study treatment or procedures 7.Subjects on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month) 9.Subject in an exclusion period or participating in another food, cosmetic or therapeutic trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Skin health Scale (0-9), Cognitive Assessment Questionnaire Score, Digestive Health Evaluation Questionnaire Score, Energy level Score(0-3)Timepoint: Day 0, Day 28 | — |
Secondary
| Measure | Time frame |
|---|---|
| Not ApplicableTimepoint: Not Applicable | — |
Countries
India
Contacts
Public ContactPuneet Mittal
CCFT Laboratories
Outcome results
None listed